Comparison of the clinical responses by the dosage of once or triple a week of MTX in patients with rheumatoid Arthritis
Not Applicable
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000002175
- Lead Sponsor
- POEM study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Disqualified in patients with rheumatoid arthritis who judged by a doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DAS28(CRP)
- Secondary Outcome Measures
Name Time Method EULAR Criteria Patient's Judgement